{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T07:02:21Z","timestamp":1782975741358,"version":"3.54.5"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T00:00:00Z","timestamp":1594166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100008220","name":"Canadian Foundation for AIDS Research","doi-asserted-by":"publisher","award":["20-004"],"award-info":[{"award-number":["20-004"]}],"id":[{"id":"10.13039\/100008220","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008220","name":"Canadian Foundation for AIDS Research","doi-asserted-by":"publisher","award":["16-012"],"award-info":[{"award-number":["16-012"]}],"id":[{"id":"10.13039\/100008220","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["HET-85515"],"award-info":[{"award-number":["HET-85515"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["TCO-125269"],"award-info":[{"award-number":["TCO-125269"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015382","name":"Centre for Blood Research, University of British Columbia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015382","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de la Recherche du Qu\u00e9bec-Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,24]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Combination antiretroviral therapy (cART) during pregnancy prevents vertical transmission, but many antiretrovirals cross the placenta and several can affect mitochondria. Exposure to maternal human immunodeficiency virus (HIV) and\/or cART could have long-term effects on children who are HIV exposed and uninfected (CHEU). Our objective was to compare blood mitochondrial DNA (mtDNA) content in CHEU and children who are HIV unexposed and uninfected (CHUU), at birth and in early life.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Whole-blood mtDNA content at birth and in early life (age 0\u20133 years) was compared cross-sectionally between CHEU and CHUU. Longitudinal changes in mtDNA content among CHEU was also evaluated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>At birth, CHEU status and younger gestational age were associated with higher mtDNA content. These remained independently associated with mtDNA content in multivariable analyses, whether considering all infants, or only those born at term. Longitudinally, CHEU mtDNA levels remained unchanged during the first 6 months of life, and gradually declined thereafter. A separate age- and sex-matched cross-sectional analysis (in 214 CHEU and 214 CHUU) illustrates that the difference in mtDNA between the groups remains detectable throughout the first 3 years of life.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The persistently elevated blood mtDNA content observed among CHEU represents a long-term effect, possibly resulting from in utero stresses related to maternal HIV and\/or cART. The clinical impact of altered mtDNA levels is unclear.<\/jats:p><\/jats:sec>","DOI":"10.1093\/infdis\/jiaa410","type":"journal-article","created":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T03:38:17Z","timestamp":1593833897000},"page":"621-631","source":"Crossref","is-referenced-by-count":13,"title":["Elevated Blood Mitochondrial DNA in Early Life Among Uninfected Children Exposed to Human Immunodeficiency Virus and Combination Antiretroviral Therapy in utero"],"prefix":"10.1093","volume":"223","author":[{"given":"Abhinav","family":"Ajaykumar","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada"},{"name":"Centre for Blood Research, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayanne","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Kakkar","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, CHU Sainte-Justine, Universit\u00e9 de Montr\u00e9al, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Brophy","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children\u2019s Hospital of Eastern Ontario, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ari","family":"Bitnun","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane","family":"Alimenti","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada"},{"name":"BC Women\u2019s Hospital and Health Centre, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Soudeyns","sequence":"additional","affiliation":[{"name":"Unit\u00e9 d\u2019Immunopathologie Virale, Centre de Recherche du CHU Sainte-Justine, Montreal, Quebec, Canada"},{"name":"Department of Microbiology, Infectiology & Immunology, Faculty of Medicine, Universit\u00e9 de Montr\u00e9al, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Saberi","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada"},{"name":"Centre for Blood Research, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianne Y K","family":"Albert","sequence":"additional","affiliation":[{"name":"Women\u2019s Health Research Institute, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah M","family":"Money","sequence":"additional","affiliation":[{"name":"BC Women\u2019s Hospital and Health Centre, Vancouver, British Columbia, Canada"},{"name":"Women\u2019s Health Research Institute, Vancouver, British Columbia, Canada"},{"name":"Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne C F","family":"C\u00f4t\u00e9","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada"},{"name":"Centre for Blood Research, University of British Columbia, Vancouver, British Columbia, Canada"},{"name":"Women\u2019s Health Research Institute, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"CIHR Team in Cellular Aging and HIV Comorbidities in Women and Children (Children and Women: AntiRetrovirals and Markers of Aging [CARMA])","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neora","family":"Pick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Normand","family":"Lapointe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerilynn","family":"Prior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Lou Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,7,8]]},"reference":[{"key":"2021030413570485200_CIT0001","first-page":"78","volume-title":"Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV","author":"World Health Organization","year":"2015"},{"key":"2021030413570485200_CIT0002","doi-asserted-by":"crossref","first-page":"e172222","DOI":"10.1001\/jamapediatrics.2017.2222","article-title":"Comparative safety of antiretroviral treatment regimens in pregnancy","volume":"171","author":"Zash","year":"2017","journal-title":"JAMA Pediatr"},{"key":"2021030413570485200_CIT0003","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00404-016-4271-y","article-title":"Pregnancy outcomes in HIV-positive women: a retrospective cohort study","volume":"295","author":"Arab","year":"2017","journal-title":"Arch Gynecol Obstet"},{"key":"2021030413570485200_CIT0004","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/COH.0000000000000300","article-title":"Health and survival of HIV perinatally exposed but uninfected children born to HIV-infected mothers","volume":"11","author":"Desmonde","year":"2016","journal-title":"Curr Opin HIV AIDS"},{"key":"2021030413570485200_CIT0005","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3389\/fimmu.2016.00310","article-title":"Linking susceptibility to infectious diseases to immune system abnormalities among HIV-exposed uninfected infants","volume":"7","author":"Ruck","year":"2016","journal-title":"Front Immunol"},{"key":"2021030413570485200_CIT0006","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/QAI.0000000000000161","article-title":"Altered innate immune development in HIV-exposed uninfected infants","volume":"66","author":"Reikie","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2021030413570485200_CIT0007","doi-asserted-by":"crossref","first-page":"e598","DOI":"10.1542\/peds.2004-0955","article-title":"Hyperlactatemia in human immunodeficiency virus-uninfected infants who are exposed to antiretrovirals","volume":"114","author":"Noguera","year":"2004","journal-title":"Pediatrics"},{"key":"2021030413570485200_CIT0008","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/QAD.0000000000000916","article-title":"Antiretroviral exposure during pregnancy and adverse outcomes in HIV-exposed uninfected infants and children using a trigger-based design","volume":"30","author":"Williams","year":"2016","journal-title":"AIDS"},{"key":"2021030413570485200_CIT0009","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1056\/NEJMoa1905230","article-title":"Neural-tube defects and antiretroviral treatment regimens in Botswana","volume":"381","author":"Zash","year":"2019","journal-title":"N Engl J Med"},{"key":"2021030413570485200_CIT0010","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1080\/09540121.2014.920949","article-title":"Neurodevelopmental outcomes in HIV-exposed-uninfected children versus those not exposed to HIV","volume":"26","author":"Kerr","year":"2014","journal-title":"AIDS Care"},{"key":"2021030413570485200_CIT0011","first-page":"1","article-title":"Risk for speech and language impairments in pre-school aged HIV-exposed uninfected children with in utero combination antiretroviral exposure","volume":"37","author":"Rice","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"2021030413570485200_CIT0012","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1097\/QAD.0000000000001985","article-title":"Neurodevelopmental outcomes and in-utero antiretroviral exposure in HIV-exposed uninfected children","volume":"32","author":"Piske","year":"2018","journal-title":"AIDS"},{"key":"2021030413570485200_CIT0013","doi-asserted-by":"crossref","first-page":"S323","DOI":"10.1097\/QAD.0000000000000357","article-title":"Cognitive and language outcomes in HIV-uninfected infants exposed to combined antiretroviral therapy in utero and through extended breast-feeding","volume":"28(suppl 3)","author":"Ngoma","year":"2014","journal-title":"AIDS"},{"key":"2021030413570485200_CIT0014","doi-asserted-by":"crossref","first-page":"e518","DOI":"10.1016\/S2352-3018(19)30083-9","article-title":"Neurodevelopmental effects of ante-partum and post-partum antiretroviral exposure in HIV-exposed and uninfected children versus HIV-unexposed and uninfected children in Uganda and Malawi: a prospective cohort study","volume":"6","author":"Boivin","year":"2019","journal-title":"Lancet HIV"},{"key":"2021030413570485200_CIT0015","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.mito.2012.10.011","article-title":"Is mitochondrial DNA content a potential biomarker of mitochondrial dysfunction?","volume":"13","author":"Malik","year":"2013","journal-title":"Mitochondrion"},{"key":"2021030413570485200_CIT0016","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0140-6736(99)07219-0","article-title":"Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues","volume":"354","author":"Blanche","year":"1999","journal-title":"Lancet"},{"key":"2021030413570485200_CIT0017","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1097\/00002030-200308150-00006","article-title":"Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants: clinical screening in a large prospective cohort","volume":"17","author":"Barret","year":"2003","journal-title":"AIDS"},{"key":"2021030413570485200_CIT0018","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1097\/QAD.0b013e3280d5a786","article-title":"In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children","volume":"21","author":"Brogly","year":"2007","journal-title":"AIDS"},{"key":"2021030413570485200_CIT0019","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1089\/aid.2010.0204","article-title":"Short communication: transplacental nucleoside analogue exposure and mitochondrial parameters in HIV-uninfected children","volume":"27","author":"Brogly","year":"2011","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2021030413570485200_CIT0020","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1097\/00002030-199814000-00004","article-title":"Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway","volume":"12","author":"Brinkman","year":"1998","journal-title":"AIDS"},{"key":"2021030413570485200_CIT0021","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJMoa012035","article-title":"Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients","volume":"346","author":"C\u00f4t\u00e9","year":"2002","journal-title":"N Engl J Med"},{"key":"2021030413570485200_CIT0022","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1385\/CT:4:3:207","article-title":"Oxidative stress in NRTI-induced toxicity: evidence from clinical experience and experiments in vitro and in vivo","volume":"4","author":"Day","year":"2004","journal-title":"Cardiovasc Toxicol"},{"key":"2021030413570485200_CIT0023","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nrd1201","article-title":"Mitochondrial toxicity of NRTI antiviral drugs: an integrated cellular perspective","volume":"2","author":"Lewis","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"2021030413570485200_CIT0024","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s13181-013-0325-8","article-title":"A review of the toxicity of HIV medications","volume":"10","author":"Margolis","year":"2014","journal-title":"J Med Toxicol"},{"key":"2021030413570485200_CIT0025","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1128\/AAC.48.11.4332-4336.2004","article-title":"Maternal-fetal transfer and amniotic fluid accumulation of nucleoside analogue reverse transcriptase inhibitors in human immunodeficiency virus-infected pregnant women","volume":"48","author":"Chappuy","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"2021030413570485200_CIT0026","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3851\/IMP1918","article-title":"Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the fetal compartment (placenta and amniotic fluid)","volume":"16","author":"Else","year":"2011","journal-title":"Antivir Ther"},{"key":"2021030413570485200_CIT0027","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00126334-200306010-00010","article-title":"Long-term mitochondrial toxicity in HIV-uninfected infants born to HIV-infected mothers","volume":"33","author":"Poirier","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2021030413570485200_CIT0028","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/00002030-200404300-00009","article-title":"Mitochondrial damage and DNA depletion in cord blood and umbilical cord from infants exposed in utero to Combivir","volume":"18","author":"Divi","year":"2004","journal-title":"AIDS"},{"key":"2021030413570485200_CIT0029","doi-asserted-by":"crossref","first-page":"e1189","DOI":"10.1542\/peds.2008-2771","article-title":"Antiretroviral exposure and lymphocyte mtDNA content among uninfected infants of HIV-1-infected women","volume":"124","author":"Aldrovandi","year":"2009","journal-title":"Pediatrics"},{"key":"2021030413570485200_CIT0030","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/QAD.0b013e32834f3232","article-title":"Perinatal outcomes, mitochondrial toxicity and apoptosis in HIV-treated pregnant women and in-utero-exposed newborn","volume":"26","author":"Hern\u00e0ndez","year":"2012","journal-title":"AIDS"},{"key":"2021030413570485200_CIT0031","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1097\/QAD.0000000000001647","article-title":"Lower mitochondrial DNA and altered mitochondrial fuel metabolism in HIV-exposed uninfected infants in Cameroon","volume":"31","author":"Jao","year":"2017","journal-title":"AIDS"},{"key":"2021030413570485200_CIT0032","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1086\/591253","article-title":"Perinatal exposure to antiretroviral therapy is associated with increased blood mitochondrial DNA levels and decreased mitochondrial gene expression in infants","volume":"198","author":"C\u00f4t\u00e9","year":"2008","journal-title":"J Infect Dis"},{"key":"2021030413570485200_CIT0033","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1310\/hct0902-126","article-title":"Increased mtDNA levels without change in mitochondrial enzymes in peripheral blood mononuclear cells of infants born to HIV-infected mothers on antiretroviral therapy","volume":"9","author":"McComsey","year":"2008","journal-title":"HIV Clin Trials"},{"key":"2021030413570485200_CIT0034","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1468-1293.2011.00945.x","article-title":"Effects of in utero antiretroviral exposure on mitochondrial DNA levels, mitochondrial function and oxidative stress","volume":"13","author":"Ross","year":"2012","journal-title":"HIV Med"},{"key":"2021030413570485200_CIT0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/v10020077","article-title":"Blood mitochondrial DNA content in HIV-exposed uninfected children with autism spectrum disorder","volume":"10","author":"Budd","year":"2018","journal-title":"Viruses"},{"key":"2021030413570485200_CIT0036","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/infdis\/jix618","article-title":"Leukocyte telomere length at birth and during the early life of children exposed to but uninfected with HIV after in utero exposure to antiretrovirals","volume":"217","author":"Ajaykumar","year":"2018","journal-title":"J Infect Dis"},{"key":"2021030413570485200_CIT0037","doi-asserted-by":"crossref","first-page":"E35","DOI":"10.1542\/peds.108.2.e35","article-title":"A new and improved population-based Canadian reference for birth weight for gestational age","volume":"108","author":"Kramer","year":"2001","journal-title":"Pediatrics"},{"key":"2021030413570485200_CIT0038","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jmoldx.2018.05.001","article-title":"A monochrome multiplex real-time quantitative PCR assay for the measurement of mitochondrial DNA content","volume":"20","author":"Hsieh","year":"2018","journal-title":"J Mol Diagn"},{"key":"2021030413570485200_CIT0039","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.tips.2011.07.007","article-title":"Mitochondrial interference by anti-HIV drugs: mechanisms beyond Pol-\u03b3 inhibition","volume":"32","author":"Apostolova","year":"2011","journal-title":"Trends Pharmacol Sci"},{"key":"2021030413570485200_CIT0040","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.1128\/AAC.00893-07","article-title":"Impact of nucleoside reverse transcriptase inhibitors on mitochondria in human immunodeficiency virus type 1-infected children receiving highly active antiretroviral therapy","volume":"51","author":"Saitoh","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"2021030413570485200_CIT0041","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1086\/375353","article-title":"Mitochondrial:nuclear DNA ratios in peripheral blood cells from human immunodeficiency virus (HIV)-infected patients who received selected HIV antiretroviral drug regimens","volume":"187","author":"C\u00f4t\u00e9","year":"2003","journal-title":"J Infect Dis"},{"key":"2021030413570485200_CIT0042","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1093\/jac\/dkn097","article-title":"Changes in metabolic toxicity after switching from stavudine\/didanosine to tenofovir\/lamivudine\u2014a Staccato trial substudy","volume":"61","author":"Ananworanich","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"2021030413570485200_CIT0043","doi-asserted-by":"crossref","first-page":"947","DOI":"10.33549\/physiolres.931246","article-title":"The developmental changes in mitochondrial DNA content per cell in human cord blood leukocytes during gestation","volume":"57","author":"Pejznochov\u00e1","year":"2008","journal-title":"Physiol Res"},{"key":"2021030413570485200_CIT0044","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.placenta.2017.05.008","article-title":"Mitochondrial DNA content and methylation in fetal cord blood of pregnancies with placental insufficiency","volume":"55","author":"Novielli","year":"2017","journal-title":"Placenta"},{"key":"2021030413570485200_CIT0045","doi-asserted-by":"crossref","first-page":"19933","DOI":"10.7448\/IAS.18.1.19933","article-title":"Risk factors for pre-term birth in a Canadian cohort of HIV-positive women: role of ritonavir boosting?","volume":"18","author":"Kakkar","year":"2015","journal-title":"J Int AIDS Soc"},{"key":"2021030413570485200_CIT0046","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejogrb.2016.03.028","article-title":"Antiretroviral therapy during pregnancy and risk of preterm birth","volume":"201","author":"Gagnon","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2021030413570485200_CIT0047","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1471-0528.2006.01183.x","article-title":"The AmRo study: pregnancy outcome in HIV-1-infected women under effective highly active antiretroviral therapy and a policy of vaginal delivery","volume":"114","author":"Boer","year":"2007","journal-title":"BJOG"},{"key":"2021030413570485200_CIT0048","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/09603123.2016.1268677","article-title":"Prenatal exposure to tobacco smoke leads to increased mitochondrial DNA content in umbilical cord serum associated to reduced gestational age","volume":"27","author":"Pirini","year":"2017","journal-title":"Int J Environ Health Res"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiaa410\/33620011\/jiaa410.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/223\/4\/621\/36415598\/jiaa410.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/223\/4\/621\/36415598\/jiaa410.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T02:12:07Z","timestamp":1667268727000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/223\/4\/621\/5868548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,8]]},"references-count":48,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,7,8]]},"published-print":{"date-parts":[[2021,2,24]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiaa410","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,2,15]]},"published":{"date-parts":[[2020,7,8]]}}}